ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Interventional Pain Medicine

Top Interventional Pain Medicine Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NOSHEEN HASAN MD

Interventional Pain Medicine

8,818

$807K

783
122 are 65+

86%
patients receiving schedule two controlled substances

Avg: 41%

12%
patients receiving schedule three controlled substances

Avg: 25%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 19%

$91
Average prescription price

Avg: $98

DOUGLAS MILOSAVLJEVIC M.D.

Interventional Pain Medicine

2,760

$248K

117
17 are 65+

76%
patients receiving schedule two controlled substances

Avg: 41%

25%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 19%

$90
Average prescription price

Avg: $98

STEVEN DONATELLO M.D.

Interventional Pain Medicine

2,614

$506K

260
137 are 65+

57%
patients receiving schedule two controlled substances

Avg: 41%

27%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 19%

$193
Average prescription price

Avg: $98

EUGENIA HORD MD

Interventional Pain Medicine

2,132

$358K

213
138 are 65+

16%
patients receiving schedule two controlled substances

Avg: 41%

15%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 19%

$168
Average prescription price

Avg: $98

SALEEM AWAN MD

Interventional Pain Medicine

1,659

$109K

191
83 are 65+

72%
patients receiving schedule two controlled substances

Avg: 41%

26%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 19%

$66
Average prescription price

Avg: $98

JUAN ALBINO-RODRIGUEZ M.D.

Interventional Pain Medicine

1,324

$107K

189
132 are 65+

36%
patients receiving schedule two controlled substances

Avg: 41%

29%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 19%

$80
Average prescription price

Avg: $98

DOUGLAS YEATMAN M.D.

Interventional Pain Medicine

1,290

$149K

113
50 are 65+

59%
patients receiving schedule two controlled substances

Avg: 41%

32%
patients receiving schedule three controlled substances

Avg: 25%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 19%

$116
Average prescription price

Avg: $98

NANCY BRATANOW M.D.

Interventional Pain Medicine

1,142

$139K

84
49 are 65+

44%
patients receiving schedule two controlled substances

Avg: 41%

14%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 19%

$122
Average prescription price

Avg: $98

DAVID LINDLEY DO

Interventional Pain Medicine

1,021

$60.3K

242
105 are 65+

36%
patients receiving schedule two controlled substances

Avg: 41%

33%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 19%

$59
Average prescription price

Avg: $98

AHMET DERVISH MD

Interventional Pain Medicine

781

$28.2K

193
78 are 65+

30%
patients receiving schedule two controlled substances

Avg: 41%

44%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 19%

$36
Average prescription price

Avg: $98

MARK AASEN MD

Interventional Pain Medicine

724

$64.3K

162
77 are 65+

52%
patients receiving schedule two controlled substances

Avg: 41%

22%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 19%

$89
Average prescription price

Avg: $98

NIKHIL PATEL M.D.

Interventional Pain Medicine

719

$47.8K

146
55 are 65+

39%
patients receiving schedule two controlled substances

Avg: 41%

17%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 19%

$67
Average prescription price

Avg: $98

MICHELLE BENSEN MD

Interventional Pain Medicine

668

$58.3K

213
72 are 65+

54%
patients receiving schedule two controlled substances

Avg: 41%

25%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 19%

$87
Average prescription price

Avg: $98

CHANDUR PIRYANI MD

Interventional Pain Medicine

626

$30.6K

86
40 are 65+

49%
patients receiving schedule two controlled substances

Avg: 41%

28%
patients receiving schedule three controlled substances

Avg: 25%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 19%

$49
Average prescription price

Avg: $98

LARS OSTMAN MD

Interventional Pain Medicine

614

$69.4K

99
69 are 65+

31%
patients receiving schedule two controlled substances

Avg: 41%

30%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 19%

$113
Average prescription price

Avg: $98

KATHERINE LIAO MD

Interventional Pain Medicine

606

$20K

89
42 are 65+

28%
patients receiving schedule two controlled substances

Avg: 41%

28%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 19%

$33
Average prescription price

Avg: $98

NILESHKUMAR PATEL MD

Interventional Pain Medicine

547

$32.1K

236
99 are 65+

28%
patients receiving schedule two controlled substances

Avg: 41%

22%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 19%

$59
Average prescription price

Avg: $98

MARCO ARAUJO MD

Interventional Pain Medicine

497

$45.1K

139
43 are 65+

30%
patients receiving schedule two controlled substances

Avg: 41%

22%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 19%

$91
Average prescription price

Avg: $98

ROHAAN MEHTA M.D.

Interventional Pain Medicine

418

$18.7K

154
81 are 65+

27%
patients receiving schedule two controlled substances

Avg: 41%

31%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 19%

$45
Average prescription price

Avg: $98

JAMES LEEK M.D.

Interventional Pain Medicine

403

$14.7K

78
45 are 65+

18%
patients receiving schedule two controlled substances

Avg: 41%

32%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 19%

$37
Average prescription price

Avg: $98

RICHARD LENNERTZ M.D.

Interventional Pain Medicine

385

$41.1K

52
31 are 65+

48%
patients receiving schedule two controlled substances

Avg: 41%

44%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 19%

$107
Average prescription price

Avg: $98

ALEXANDER YAKOVLEV MD

Interventional Pain Medicine

327

$22.3K

78
21 are 65+

72%
patients receiving schedule two controlled substances

Avg: 41%

0%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 19%

$68
Average prescription price

Avg: $98

MARK SCHLIMGEN MD

Interventional Pain Medicine

171

$5,796

71
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 41%

30%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 19%

$34
Average prescription price

Avg: $98

ROMEO BIBOSO MD

Interventional Pain Medicine

107

$2,541

11
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 41%

0%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 19%

$24
Average prescription price

Avg: $98

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank